Stay updated on Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial
Sign up to get notified when there's something new on the Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial page.

Latest updates to the Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial page
- ChecktodayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.6%
- Check7 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference1%
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check58 days agoChange DetectedThe page has been updated to include new information about pneumonia and the EudraCT number, while significant details regarding the study's methodology and inclusion/exclusion criteria have been removed.SummaryDifference12%
- Check72 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled Amikacin for Gram-Negative Pneumonia Clinical Trial page.